Richard Holcomb Joins MethodSense as Chief Growth Officer

Regulatory consulting firm MethodSense has appointed Richard Holcomb as chief growth officer (CGO). A distinguished entrepreneur, investor, and growth strategist in the Research Triangle Park region (Raleigh-Durham, N.C.), Holcomb has more than four decades of experience building and scaling successful technology companies.

Holcomb’s addition is part of MethodSense’s stratagem to expand the reach and capabilities of its LuminLogic platform in order to meet the growing complexity of global life sciences regulation. With U.S. Food and Drug Administration (FDA) modernization accelerating, the need for structured, AI-ready, and traceable compliance solutions has never been more urgent, according to the company.

“Richard’s arrival comes at a moment of unprecedented transformation in our industry,” MethodSense CEO Rita King said. “He understands how to connect technology with strategy and vision, and his leadership will help us scale LuminLogic and support more innovators who are racing to bring life-saving products to market faster.”

As CGO, Holcomb will lead strategic growth initiatives that unite MethodSense’s regulatory consulting expertise with the expanding capabilities of LuminLogic, a collaborative, purpose-built compliance platform that supports regulatory submissions, quality systems, training management, risk tracking, and more.

Holcomb has founded or advised more than 25 successful companies, including Q+E Software, HAHT Commerce, and StrikeIron, each achieving strong exits. His experience spans fundraising, international growth, corporate development, and technology leadership.

“We’re entering the AI era of regulatory compliance,” Holcomb stated. “Regulators are adopting tools like the FDA’s Elsa system, and legacy submission practices just won’t cut it. Built for the future, LuminLogic is structured, collaborative, and intelligent. It’s the right platform at the right time, and I’m thrilled to help take it to the next level.”

Holcomb’s appointment also aligns with MethodSense’s evolved vision: to transform regulatory complexity into a catalyst for innovation and faster patient access. The company’s mission focuses on enabling life science teams to move with clarity and confidence, combining expert guidance, cutting-edge software, and a growing community of partners to accelerate success.

“Richard has been an advisor to MethodSense for years, and his insights have helped shape our long-term strategy,” MethodSense President and Regulatory Strategist Russ King commented. “His move into an operational leadership role reinforces our commitment to scaling responsibly, with both impact and purpose at the core.”

MethodSense is a regulatory and quality consulting firm specializing in the medical device and life sciences industries. With expertise in FDA, EU MDR, and global regulatory pathways, MethodSense helps companies achieve compliance, accelerate market entry, and ensure product quality. Its LuminLogic compliance management platform integrates regulatory processes, quality management, and lifecycle documentation into a seamless solution for achieving regulatory success.